Tag Archives: Urinalysis Market

Urinalysis Market: Aggressive Research Activities Stimulating Market Growth

According to a new market report published by Transparency Market Research “Urinalysis Market – (By Product Type – Instruments and Consumables; By Test Type – Macroscopic, Biochemical, and Sediment/Microscopic; By Test Settings – Point-of-care and Laboratory-based; By End-user – Hospitals, Independent Laboratories, Physician Practices, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2014–2024): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024”, the global urinalysis market is anticipated to expand at a CAGR of 5.4% from 2016 to 2024 to reach US$ 1.5 Bn by 2024.

Browse the full report at http://www.transparencymarketresearch.com/urinalysis-market.html

Diabetes is considered to be the leading cause of kidney failure and end-stage renal disease (ESRD) globally. According to the International Diabetes Federation (IDF), around 338 million people in the world were diagnosed with diabetes in 2014. About 3.2 million people were diagnosed with ESRD in 2015. This has resulted in larger number of patients requiring urine diagnosis and increase in usage of consumables for urinalysis. According to the WHO, diabetes accounted for an estimated 422 million deaths globally in 2014. Rising incidence of renal disease, increasing prevalence of diabetes, and other disorders are the major factors accelerating the growth of the global urinalysis market.

North America dominated the global urinalysis market, accounting for a share of over 30% in 2015. Increasing geriatric population, rapid innovation in technology, and high R&D expenditure are attributed to the growth of the urinalysis market in the region. According to National Kidney Foundation, Inc., 26 million people in the U.S. have kidney disease. These factors collectively drive the urinalysis market in North America.

Europe is a developed market for urinalysis, accounting for a share of over 20% in terms of revenue in 2015. According to the International Diabetes Federation, 387 million people across the globe have diabetes. Europe has the highest prevalence of type 1 diabetes in children. Growing number of patients requiring proper diagnosis is likely to augment the urinalysis market in the next few years. Rising prevalence of chronic diseases in Europe and development of novel laboratory testing methodologies are expected to drive the urinalysis market from 2016 to 2024.

Get Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4334

Asia Pacific accounted for the second largest share of 30% of the urinalysis market in 2015. According to the UN, there are 901 million people aged 60 and above globally. Japan has the largest geriatric population, which is expected to increase in the next few years. The rise in the geriatric population, increasing number of laboratory diagnosis tests and, increasing point of care tests lead to the upswing of urinalysis market. Rapid pace of industrialization and infrastructure development activities, and increased awareness about product safety and quality in countries such as China and India are also expected to spur demand for testing services in the region.

The market in Latin America is projected to expand at a high CAGR during the forecast period from 2016 to 2024. Large population base, high target patient pool, and increasing government initiatives to provide better health care facilities are driving the urinalysis market in Latin America.

Major players in the global urinalysis market are ARKRAY, Inc., Bio-Rad Laboratories, Inc. Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Mindray Medical International Limited, Siemens Healthineers, Sysmex Corporation, and 77 Elektronika Kft.

 

Advertisements

Urinalysis Market: Industry Players Shifting Focus towards Developing Economies

Global Urinalysis Market: Snapshot

The global market for urinalysis has been growing at a fast rate due to increased incidence of diabetes among people across the globe. On a global scale, the major cause of end-stage renal disease and kidney failure is diabetes. The International Diabetes Federation (IDF) found that approximately 338 million new cases of diabetes were recorded in 2014, while as many as 3.2 million suffered from end-stage renal disease (ESRD) in 2015.

Urinalysis is a set of tests for detecting some common diseases such as kidney disorders, diabetes, liver problems, and urinary tract infections. The test consists of several microscopic, visual, and chemical examinations that identify cells, levels of creatinine, epithelial cells, and substances such as casts or crystals in the urine. These detections are crucial in the process of disease diagnosis. These tests are also conducted during routine pregnancy check-ups, when one is admitted to the hospital, and even before a surgery.

Browse the full report at http://www.transparencymarketresearch.com/urinalysis-market.html

The global market for urinalysis is expected to grow steadily with a CAGR of 5.4%. In 2015, the market was valued at US$929.9 mn, which will rise to US$1.5 bn by the end of 2024.

By Test Setting, Laboratory-based Segment to Continue to Grow

In terms of test setting, the urinalysis market was dominated by the laboratory-based segment in 2015 and is expected to continue to hold its dominant position over the coming years. This development is due to the increasing geriatric population, increased frequency of unhealthy lifestyles, and growing incidence of infectious diseases worldwide.

On the basis of type of test, the biochemical segment lead the urinalysis market in 2015, on account of the widely accepted usage of dipsticks (reagent strips) that detect the presence of constituents in urine. Also, it is convenient to operate this technique as it is readily available. The hospital segment leads the market in terms of end users in the global market for urinalysis.

Among the key products in the urinalysis market, consumables occupy the foremost position. High rate of acceptance of single-use, rigid, and sterile disposable products is boosting the growth of this segment. Under the consumables segment, plastic consumables will emerge as a terrain for immense opportunities.

Get Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4334

Japan at Headmost Position in Asia Pacific Segment

Among the key geographical segments, it was North America that led the global market in 2015, accounting for a nearly 30.0% share. The U.S. is home to around 26 million kidney patients, according to the findings of National Kidney Foundation. Increasing incidence of urinary tract infections in the U.S. is also responsible for the expansion of the urinalysis market in North America. Latin America, too, will grow at an impressive CAGR between 2016 and 2024. The key reasons for growth are favorable government policies, massive population base, and a large patient pool.

Asia Pacific is projected to be a major market furnishing lucrative opportunities, with Japan at the foremost place. An increase in aging population, rapid industrialization, growing number of laboratory diagnosis tests, and high adoption of point-of-care testing have been the major reasons for Japan’s rise as a key regional market. Apart from Japan, India and China are also expected to expand their urinalysis market on account of numerous infrastructural development projects.

The major companies in the global urinalysis market include Danaher Corporation (Beckman Coulter, Inc.), ARKRAY, Inc., Sysmex Corporation, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Siemens Healthineers, 77 Elektronika Kft, and Mindray Medical International Limited.

 

New Trends of Urinalysis Market with Worldwide Industry Analysis to 2024

According to a new market report published by Transparency Market Research “Urinalysis Market – (By Product Type – Instruments and Consumables; By Test Type – Macroscopic, Biochemical, and Sediment/Microscopic; By Test Settings – Point-of-care and Laboratory-based; By End-user – Hospitals, Independent Laboratories, Physician Practices, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2014–2024): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024”, the global urinalysis market is anticipated to expand at a CAGR of 5.4% from 2016 to 2024 to reach US$ 1.5 Bn by 2024.

Browse the full report at http://www.transparencymarketresearch.com/urinalysis-market.html

Diabetes is considered to be the leading cause of kidney failure and end-stage renal disease (ESRD) globally. According to the International Diabetes Federation (IDF), around 338 million people in the world were diagnosed with diabetes in 2014. About 3.2 million people were diagnosed with ESRD in 2015. This has resulted in larger number of patients requiring urine diagnosis and increase in usage of consumables for urinalysis. According to the WHO, diabetes accounted for an estimated 422 million deaths globally in 2014. Rising incidence of renal disease, increasing prevalence of diabetes, and other disorders are the major factors accelerating the growth of the global urinalysis market.

North America dominated the global urinalysis market, accounting for a share of over 30% in 2015. Increasing geriatric population, rapid innovation in technology, and high R&D expenditure are attributed to the growth of the urinalysis market in the region. According to National Kidney Foundation, Inc., 26 million people in the U.S. have kidney disease. These factors collectively drive the urinalysis market in North America.

Europe is a developed market for urinalysis, accounting for a share of over 20% in terms of revenue in 2015. According to the International Diabetes Federation, 387 million people across the globe have diabetes. Europe has the highest prevalence of type 1 diabetes in children. Growing number of patients requiring proper diagnosis is likely to augment the urinalysis market in the next few years. Rising prevalence of chronic diseases in Europe and development of novel laboratory testing methodologies are expected to drive the urinalysis market from 2016 to 2024.

Get Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4334

Asia Pacific accounted for the second largest share of 30% of the urinalysis market in 2015. According to the UN, there are 901 million people aged 60 and above globally. Japan has the largest geriatric population, which is expected to increase in the next few years. The rise in the geriatric population, increasing number of laboratory diagnosis tests and, increasing point of care tests lead to the upswing of urinalysis market. Rapid pace of industrialization and infrastructure development activities, and increased awareness about product safety and quality in countries such as China and India are also expected to spur demand for testing services in the region.

The market in Latin America is projected to expand at a high CAGR during the forecast period from 2016 to 2024. Large population base, high target patient pool, and increasing government initiatives to provide better health care facilities are driving the urinalysis market in Latin America.

Major players in the global urinalysis market are ARKRAY, Inc., Bio-Rad Laboratories, Inc. Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Mindray Medical International Limited, Siemens Healthineers, Sysmex Corporation, and 77 Elektronika Kft.

 

Urinalysis Market Shifts to High Gear due to Rising R&D by Healthcare Industries

Urinalysis Market: Snapshot

The global urinalysis market is primarily fueled by the alarming rise in the prevalence of diabetes. Diabetes is considered to be the leading cause of kidney failure and end-stage renal disease (ESRD) globally. According to the International Diabetes Federation (IDF), an estimated 338 million new cases of diabetes were reported in 2014 and about 3.2 million people were diagnosed with ESRD in 2015. The WHO reports that diabetes accounted for an estimated 422 million deaths globally in 2014.

The growing incidence of renal disease, diabetes, and other kidney-related disorders has resulted in an increased demand for urine diagnosis and urinalysis consumables. Driven by this, the global urinalysis market is projected to expand from a valuation of US$929.9 mn in 2015 to US$1.5 bn by 2024 at a steady 5.4% CAGR therein.

Increasing Preference for Single-Use Consumables a Major Growth Factor

In terms of product, the consumables segment accounted for the leading share in the global urinalysis market in 2015 and is expected to dominate the market throughout the forecast period. The key factor driving this segment is an increase in preference toward sterile, rigid, and single-use disposable products. Within the consumables segment, plastic consumables offer substantial opportunities for new market players.

By type of test, the biochemical segment held the dominant share in the overall urinalysis market in 2015. The wide usage of reagent strips (dipsticks) is mainly responsible for the growth of this segment. Dipstick is a biochemical technique to detect constituents present in the urine. This technique is easy to follow and is available in a variety of types. Hospitals form the leading end-user segment of the urinalysis market.

On the basis of test setting, the laboratory-based segment led the urinalysis market in 2015 and is expected to show significant promise during the forecast period. The increasing prevalence of infectious diseases in developing countries, the growing incidence of lifestyle diseases, the rising geriatric population, and various technological advancements with regard to the development of faster and easy-to-use devices drive demand for laboratory-based urinalysis.

Rise in Geriatric Population Single-handedly Driving Demand for Urinalysis

North America led the global urinalysis market, accounting for a share of over 30% in 2015. Increasing geriatric population, rapid innovation in technology, and high R&D expenditure are attributed to the growth of the urinalysis market in the region. According to the National Kidney Foundation, an estimated 26 million people in the U.S. are living with kidney disease. This is also a key factor driving the urinalysis market in North America.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4334

Asia Pacific accounted for a significant share in the global urinalysis market in 2015, propelled primarily by the rise in geriatric population. According to the UN, there are 901 million people aged 60 and above globally, with Japan leading the pack. The rise in geriatric population, the increasing number of laboratory diagnosis tests, and a rise in point-of-care testing have led to the upswing of the APAC urinalysis market. The rapid pace of industrialization and infrastructure development activities, and increased awareness about product safety and quality in countries such as China and India are also expected to spur the demand for testing services in the region, thereby positively impacting the urinalysis.

The market in Latin America is projected to expand at a high CAGR during the forecast period from 2016 to 2024. A large population base, a high-target patient pool, and an increase in government initiatives to provide better healthcare facilities are driving the urinalysis market in Latin America.

Key players operating in the global urinalysis market include, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Mindray Medical International Limited, Siemens Healthineers, Sysmex Corporation, and 77 Elektronika Kft.

 

Global Urinalysis Market: Rising Demand for Point-of-care Testing (POCT) Strongly Impacting Growth, notes TMR

The global urinalysis market is highly fragment, with the top five companies accounting for a share of 41.7% in 2016. Transparency Market Research finds that these companies, namely F. Hoffman-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare, BAYER Healthcare, and Sysmex Corporation, have been dominating the scene owing to various business strategies. Acquisition is one of the most successful and widely chosen growth strategies adopted by players to strengthen their position in the urinalysis market. A case in point would be F. Hoffmann-La Roche Ltd.’s acquisition of GeneWEAVE BioSciences, Inc. in 2015.

Expanding at a steady 5.4% CAGR from 2016 to 2024, the global urinalysis market is projected to grow from a valuation of US$929.9 mn in 2015 to US$1.5 bn by 2024.

Download Free exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4334

Laboratory-based Urinalysis Holds Lion’s Share of the Market by Test Setting

Consumables was the leading product segment in 2015, accounting for a 71.0% share that year. Plastic consumables was the dominant sub-segment, accounting for approximately 53.0% share of the consumables segment in the same year. The instrument segment is likely to expand at a CAGR of 6.8% from 2016 to 2024, emerging as one of the most promising product segments. By type of test, the urinalysis biochemical test held a large share at the start of the forecast period, while the microscopic and sediments urinalysis segment will register a high growth rate. On the basis of test settings, the laboratory-based testing segment will hold the lion’s share of the market throughout the forecast period. Point-of-care testing, on the other hand, will exhibit strong growth from 2016 to 2024.

Based on end use, hospital laboratories held the leading share of the urinalysis market in terms of both test volume and revenue in 2014. The others segment, which includes industrial institutions, home testing, and nursing facilities, will witness impressive growth in the coming years. Accounting for a 35% share of the global urinalysis market in 2016, North America holds the lead position. The market in Asia Pacific, on the other hand, offers the highest growth potential.

Read Full Report: http://www.transparencymarketresearch.com/urinalysis-market.html

Benefits of Point-of-care Testing Spurs Adoption of Urinalysis

Point-of-care testing (POCT) technologies have played a vital role in the transformation of the healthcare industry. When implemented accurately, point-of-care testing can have a positive impact on patient care as well as operational efficiency. “With a rising focus on providing cost-effective and timely medical care for ambulatory patients, POC laboratory testing has become one of the fastest growing areas in the medical field,” the author of the study notes. The benefits of point-of-care testing are also reflected in urinalysis, wherein the segment is poised to witness strong growth in the coming years.

The rise in geriatric population, rapid advancement in medical technology, and the rising incidence of diabetes and renal diseases also contribute to the global urinalysis market.

In contrast, the high cost associated with advanced analyzers and the shortage of laboratory staff acts as impediments to the growth of the urinalysis market.